Skip to main content
Premium Trial:

Request an Annual Quote

Northwestern University, Open Biosystems, CytRx


Northwestern Joins Open Biosystems Open Access Program

Open Biosystems said this week that Northwestern University has joined the company's Open Access RNAi Program.

As reported by RNAi News, the program is designed to make Open Biosystems' genome-wide shRNA libraries more affordable for the company's academic customer base (see RNAi News, 2/2/2006).

By joining the program, Open Biosystems said Northwestern's community of 270 participating research labs will gain access to the company's shRNA libraries. Financial terms of the arrangement were not disclosed.

CytRx Inks Deals to Sell $13.4M in Stock, Warrants

CytRx said last week that it has entered into definitive agreements with a group of institutional investors to sell roughly $13.4 million in common stock and warrants.

Under the terms of the financing, CytRx will sell 10.65 million shares of common stock at $1.26 per share and issue warrants to purchase approximately 5.33 million shares of common stock at an exercise price of $1.54 per share. CytRx said it will net about $12.4 million through the placement.

The signing of the agreements comes at a time when CytRx is struggling under a cash crunch and is seeking funds to spin out its RNAi therapeutics operations (see RNAi News, 2/2/2006 and 2/16/2006).

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.